Saliva pursues US rapid HIV test approval:
This article was originally published in Clinica
Executive Summary
Saliva Diagnostics plans to submit its rapid, non-laboratory HIV test for FDA approval. The company, which is based in Vancouver, Washington, has hired a regulatory affairs director following the US Centres for Disease Control and Prevention's statement last month that developers of rapid HIV tests should be encouraged to apply for FDA approval (see Clinica No 724, p 1).